Intrapulmonary pharmacokinetics of cefiderocol, a novel siderophore cephalosporin, in healthy adult subjects

BACKGROUND: Cefiderocol, a novel siderophore cephalosporin, has shown potent activity against Gram-negative bacteria, including MDR pathogens. Cefiderocol is under clinical investigation for the treatment of serious Gram-negative infections including nosocomial pneumonia. OBJECTIVES: This study asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsube, Takayuki, Saisho, Yutaka, Shimada, Jingoro, Furuie, Hidetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587409/
https://www.ncbi.nlm.nih.gov/pubmed/31220260
http://dx.doi.org/10.1093/jac/dkz123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587409/
https://www.ncbi.nlm.nih.gov/pubmed/31220260
http://dx.doi.org/10.1093/jac/dkz123

Ejemplares similares